These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1974168

  • 21. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 22. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 23. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
    López-Malpartida AV, Ludeña MD, Varela G, García Pichel J.
    Lung Cancer; 2009 Jul 15; 65(1):25-33. PubMed ID: 19046792
    [Abstract] [Full Text] [Related]

  • 24. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW.
    Cancer Res; 1993 May 15; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [Abstract] [Full Text] [Related]

  • 25. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M.
    Int J Clin Pract; 2006 Jun 15; 60(6):675-82. PubMed ID: 16805752
    [Abstract] [Full Text] [Related]

  • 26. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y, Pawson T, Blackstein ME, Andrulis IL.
    Oncogene; 1990 Jun 15; 5(6):879-83. PubMed ID: 1694290
    [Abstract] [Full Text] [Related]

  • 27. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T.
    Clin Cancer Res; 1997 Jul 15; 3(7):1051-8. PubMed ID: 9815783
    [Abstract] [Full Text] [Related]

  • 28. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 29. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
    Ishihama H, Chida M, Araki O, Karube Y, Seki N, Tamura M, Umezu H, Honma K, Masawa N, Miyoshi S.
    Jpn J Clin Oncol; 2009 Jan 15; 39(1):33-6. PubMed ID: 19015148
    [Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec 15; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 31. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI.
    Princess Takamatsu Symp; 1988 Dec 15; 19():45-57. PubMed ID: 2908355
    [Abstract] [Full Text] [Related]

  • 32. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 33. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL, Baldus SE, Mönig SP, Tack D, Sinning JM, Gutschow CA, Grass G, Schneider PM, Dienes HP, Hölscher AH.
    Cancer; 2004 May 01; 100(9):1909-17. PubMed ID: 15112272
    [Abstract] [Full Text] [Related]

  • 34. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA.
    Cancer Res; 1989 Sep 15; 49(18):4968-71. PubMed ID: 2569928
    [Abstract] [Full Text] [Related]

  • 35. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B.
    Ann Thorac Surg; 2004 Nov 15; 78(5):1734-41. PubMed ID: 15511464
    [Abstract] [Full Text] [Related]

  • 36. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 15; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 37. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J, Samija M, Juretić A, Sarcević B, Sobat H.
    Coll Antropol; 2008 Sep 15; 32(3):731-6. PubMed ID: 18982744
    [Abstract] [Full Text] [Related]

  • 38. [Clinical significance of oncogene product expression in human lung cancer].
    Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug 15; 30(8):1441-7. PubMed ID: 1331597
    [Abstract] [Full Text] [Related]

  • 39. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
    Pääkkö P, Nuorva K, Kamel D, Soini Y.
    Am J Respir Cell Mol Biol; 1992 Sep 15; 7(3):325-34. PubMed ID: 1355655
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma.
    Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K.
    Eur J Cancer; 1991 Sep 15; 27(11):1372-5. PubMed ID: 1683776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.